Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia

Pure red cell aplasia (PRCA) due to neutralizing antibodies can rarely develop following treatment with epoetin. The treatment of this condition is generally unsatisfactory and immunosuppression is often recommended, which improves chances of hematological recovery. We describe a case of PRCA due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahajan, S. A., Nandagopal, N., Soni, M., Annigeri, R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663775/
https://www.ncbi.nlm.nih.gov/pubmed/26664213
http://dx.doi.org/10.4103/0971-4065.156897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663775/
https://www.ncbi.nlm.nih.gov/pubmed/26664213
http://dx.doi.org/10.4103/0971-4065.156897

Ejemplares similares